Teva Pharmaceutical Industries Newsroom

Teva Pharmaceutical Industries Options Spot-On: On April 29th, 122.66K Contracts Were Traded, With 830.07K Open Interest

Moomoo News16:30 ET

Unusual Options Activity: NEM, DECK and Others Attract Market Bets, NEM V/OI Ratio Reaches 66.7

Moomoo News13:30 ET

HSBC Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Raises Target Price to $20

Moomoo NewsApr 28 07:32 ET · Ratings

Express News | Teva : HSBC Cuts Target Price to $20 From $24

ReutersApr 28 01:32 ET

Headache For MOH With Trump's Flip-Flop On Pharma Tariff

Business TodayApr 26 10:35 ET

Express News | 'FDA Commissioner Says 'No Plans' To Pull Abortion Pill Mifepristone' - Financial Times

BenzingaApr 24 11:54 ET

BofA Securities Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $20

Moomoo NewsApr 24 06:31 ET · Ratings

Bausch Health: U.S. District Court Grants Summary Judgment in Favor of FDA, Salix, Teva Against Norwich

Dow JonesApr 17 15:44 ET

Trump Targets Medicare Price Negotiations in New Executive Order

Seeking AlphaApr 15 20:23 ET

Options Market Statistics: Ford Stock Rises Despite S&P Downgrade Warning; Options Pop

Options NewsmanApr 14 22:18 ET

Unusual Options Activity: TEVA, DAL and Others Attract Market Bets, TEVA V/OI Ratio Reaches 188.8

Moomoo NewsApr 14 16:30 ET

Teva Pharmaceutical Industries Options Spot-On: On April 14th, 92,555 Contracts Were Traded, With 845.15K Open Interest

Moomoo NewsApr 14 16:30 ET

Research Alert: CFRA Cuts Opinion On Shares Of Teva Pharmaceutical Industries To Sell From Hold

MT NewswiresApr 11 14:15 ET

Unusual Options Activity: DKS, MBLY and Others Attract Market Bets, DKS V/OI Ratio Reaches 115.4

Moomoo NewsApr 11 13:30 ET

AI replacing animal experiments? A message from the FDA has left "monkey breeders" feeling devastated, and experts state that "we are still far from the stage of implementation."

① The news that the USA FDA has publicly stated it will gradually replace animal testing requirements has led to an increase in the stock prices of AI pharmaceutical companies, impacting traditional drug evaluation CRO companies; ② Some believe this action represents a trend in Industry development. However, others believe that it is far from being implementable.

cls.cnApr 11 07:59 ET

Teva Pharmaceutical Industries (NYSE:TEVA) Pops As FDA Expands AJOVY'S Use For Pediatric Migraine Prevention

Yahoo FinanceApr 9 14:38 ET

Pharma, MedTech Stocks Bounce Back as Trump Pauses Most Tariffs

Seeking AlphaApr 9 14:26 ET

Is Teva Pharmaceutical Industries (NYSE:TEVA) A Risky Investment?

Simply Wall StApr 9 09:17 ET

Sector Update: Health Care Stocks Lean Lower Premarket Monday

MT NewswiresApr 7 09:16 ET

Teva Pharmaceuticals Shares Are Trading Higher After the Company Announced FDA Filing Acceptance for AJOVY.

BenzingaApr 7 09:00 ET